Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8020422 | 0.84 | ALDH1A1 (0.69) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL269845 | 0.82 | TDP1 (1.00) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL3462835 | 0.82 | TDP1 (1.00) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| Ammonia Solution, Strong SCHEMBL10880861 | 0.81 | TDP1 (0.96) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL21772081 | 0.81 | TDP1 (0.96) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| Aniline SCHEMBL22169236 | 0.81 | TDP1 (0.82) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL4229181 | 0.79 | ALDH1A1 (0.69) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL4687037 | 0.79 | ALDH1A1 (0.61) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL4237867 | 0.79 | ALDH1A1 (0.61) | TDP1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL92071 | 0.79 | ALDH1A1 (0.95) | TDP1ALDH1A1KMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10996218-B2 | Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles | OURNEXTBABY LLC (US) | 2021-05-04 | — | — | US | disclosed |
| US-20180292399-A1 | METHODS FOR CHEMOTAXIS / REDOX DRIVEN SEPARATION OF X AND Y CHROMOSOME BEARING SPERM AND THEIR INSEMINATION IN GENDER SPECIFIC MENSTRUAL CYCLES | GENDERQUEST LLC (US) | 2018-10-11 | — | — | US | disclosed |
| US-10018625-B2 | Use of female mammal's urine for determination of fetal gender related characteristics | UROBIOLOGICS LLC (US) | 2018-07-10 | — | — | US | disclosed |
| EP-2863220-B1 | Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics | UROBIOLOGICS LLC (US) | 2017-09-06 | — | — | EP | disclosed |
| EP-2619573-B1 | USE OF FEMALE MAMMAL'S URINE FOR DETERMINATION OF FETAL GENDER RELATED CHARACTERISTICS | UROBIOLOGICS LLC (US) | 2017-06-14 | — | — | EP | disclosed |
| US-20150316540-A1 | REDUCING/OXIDIZING ACTIVITY OF MATERNAL URINE AS INDICATOR OF FETAL GENDER RELATED CHARACTERISTICS | UROBIOLOGICS LLC | 2015-11-05 | — | — | US | disclosed |
| US-9057720-B2 | Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics | UROBIOLOGICS LLC (US) | 2015-06-16 | — | — | US | disclosed |
| EP-2863220-A2 | Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics | Urobiologics LLC (US) | 2015-04-22 | — | — | EP | disclosed |
| US-20140302537-A1 | Use of Female Mammal's Urine for Determination of Fetal Gender Related Characteristics | OURNEXTBABY LLC | 2014-10-09 | — | — | US | disclosed |
| US-8759109-B2 | Use of female mammal's urine for determination of fetal gender related characteristics | UROBIOLOGICS LLC (US) | 2014-06-24 | — | — | US | disclosed |
| EP-2619573-A1 | USE OF FEMALE MAMMAL'S URINE FOR DETERMINATION OF FETAL GENDER RELATED CHARACTERISTICS | Urobiologics LLC (US) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012036691-A1 | USE OF FEMALE MAMMAL'S URINE FOR DETERMINATION OF FETAL GENDER RELATED CHARACTERISTICS | UROBIOLOGICS LLC (US) | 2012-03-22 | — | — | WO | disclosed |
| US-20110230453-A1 | Use of Female Mammal's Urine for Determination of Fetal Gender Related Characteristics | UROBIOLOGICS LLC (US) | 2011-09-22 | — | — | US | disclosed |
| EP-2257803-A2 | REDUCING/OXIDIZING ACTIVITY OF MATERNAL URINE AS INDICATOR OF FETAL GENDER RELATED CHARACTERISTICS | Urobiologics LLC (US) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009114579-A2 | REDUCING/OXIDIZING ACTIVITY OF MATERNAL URINE AS INDICATOR OF FETAL GENDER RELATED CHARACTERISTICS | UROBIOGICS LLC (US) | 2009-09-17 | — | — | WO | disclosed |
| US-20090233321-A1 | Reducing/Oxidizing Activity of Maternal Urine As Indicator of Fetal Gender Related Characteristics | UROBIOLOGICS LLC (US) | 2009-09-17 | — | — | US | disclosed |
| US-4160696-A | Ascorbic acid determination | EASTMAN KODAK COMPANY (US) | 1979-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230453-A1 | Use of Female Mammal's Urine for Determination of Fetal Gender Related Characteristics | SHBG, PGF, CYP19A1 | TDP1 3082/4885ALDH1A1 243/4885KMT2A 4397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.